Please ensure Javascript is enabled for purposes of website accessibility
Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 18, 2018 5:05 P.M.
Form: S-1
CIK: 0001492422
Company Name: Apellis Pharmaceuticals, Inc.
File Number: 333-224303